Cigna (CI) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Cigna · Health Care · ref. ETF XLV · 72 calls · price $277.67
What the company does: The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.
📈 Cigna (CI) stock price
$277.67-7.1% over range
Aug 28, 25low $244.41 · high $311Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
69% recommend buying · 13 analysts
📊 JPI status : Cigna is no longer in our current JPI rankings, but appeared in the past (2020) — its upside may be behind it. See the stocks picked in 2020 →
🎯 CI price target & analyst consensus — price $278
The price target · all analysts combined (13 targets)
Highest target · 1 firm of 13$400+44.1%
Median target · of 13 targets$340+22.4%
Lowest target · 1 firm of 13$302+8.8%
Current price$277.67
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
13100%
$302 ↔ $400
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Jefferies — 72% of its targets hit on this sector (380 calls tested). It aims for $307 (+11 %), call made on August 5, 2026, maturing on August 5, 2027 (23 d ago).
The 7 reliable analysts
$320+15 %
The 6 other firms
$351+26 %
How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $320 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy969%
Hold431%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 CI price target all
All 72 calls, one by one, with our verdict on each firm.
→ See all 72 targets, analyst by analyst💡 The best analysts on CI most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in CI? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Cigna? The JPI assistant answers using our backtest data.
💰 Cigna dividend: yield, history & growth › open the full page
2.22%annual yield
📈 Steady dividend — 5 yrs of consecutive dividend increases
That's ~$6.14 per share per year.
📈 Cigna fundamentals: valuation, margins & growth › open the full page
P/E 11.5Net margin 2.3 %Revenue growth +6.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 4 %
2023
Rev +8%Profit −23%
2024
Rev +27%Profit −34%
2025
Rev +11%Profit +73%
🔎 Detailed analyses
🏛️ Which US Congress members hold Cigna (CI)?
10 Congress members have disclosed CI buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Thomas Suozzi 4× · 38%Lois Frankel 3× · 45%Gilbert Cisneros 3× · 48%Alan Lowenthal 2× · 35%Julie Johnson 2× · 35%Michael Burgess 1× · 40%Jefferson Shreve 1× · 40%Jared Moskowitz 1× · 25%Valerie Hoyle 1×Julia Letlow 1×
✅ Historical analyst reliability on CI
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Monness, Crespi, Hardt | 100% | +35.6% | 2 |
| Jefferies ↗ | 100% | +23.7% | 10 |
| SunTrust Robinson Humphrey | 100% | +21.8% | 2 |
| BMO Capital ↗ | 88% | +36.9% | 8 |
| Citigroup ↗ | 86% | +8.9% | 7 |
| UBS ↗ | 80% | +13.7% | 10 |
| B of A Securities ↗ | 80% | +6.4% | 5 |
| Wells Fargo ↗ | 75% | +6.6% | 4 |
| Deutsche Bank ↗ | 74% | +23.7% | 23 |
| Oppenheimer ↗ | 70% | +14.7% | 10 |
See the other 19 firms
| Leerink Swann | 0% | -16.4% | 3 |
| Baird ↗ | 0% | -9.9% | 3 |
| Cantor Fitzgerald ↗ | 0% | -8.8% | 13 |
| Guggenheim ↗ | 20% | -11.2% | 5 |
| Barclays ↗ | 25% | -2.7% | 12 |
| Cowen & Co. | 33% | -8.0% | 3 |
| RBC Capital ↗ | 33% | +0.7% | 9 |
| Piper Sandler ↗ | 33% | +2.9% | 6 |
| Bernstein ↗ | 50% | -2.0% | 2 |
| Truist Securities ↗ | 50% | +1.3% | 8 |
| Goldman Sachs ↗ | 50% | +12.0% | 2 |
| Susquehanna ↗ | 50% | +15.2% | 2 |
| Sterne Agee | 50% | +37.5% | 2 |
| JP Morgan ↗ | 58% | +16.1% | 12 |
| Credit Suisse | 62% | +18.2% | 13 |
| Stephens & Co. ↗ | 64% | +6.7% | 11 |
| Morgan Stanley ↗ | 64% | +9.6% | 25 |
| Mizuho ↗ | 64% | +9.8% | 11 |
| Raymond James ↗ | 67% | +16.2% | 18 |
📊 What $1,000 invested in Cigna would be worth › open the full page
In short — $1,000 invested in Cigna 10 years ago would be worth $1,975 today, i.e. +7%/yr on average. Best year: 2017 (+32%), worst: 2018 (-11%). Price performance, excluding dividends.
If I'd invested $1,000 in Cigna
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $893 | -11% |
| 3 years ago | $944 | -6% |
| 5 years ago | $1,313 | +31% |
Return by year (Cigna)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -5% | $951 (-5%) |
| 2025 | -6% | $893 (-11%) |
| 2024 | -8% | $820 (-18%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Cigna
Loading news…
📋 All analyst calls on CI
Filtered on — · ✕ show all
■ Hold neutral · not a buy · 🎯$307
Price at call : $274.05 — gap to target +12%
Today : $277.67 — gap to target +11%
🎯 on CI : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Raymond James ↗
Aug 3, 26
▲ Outperform · 🎯$320
Price at call : $274.05 — upside +17%
Today : $277.67 — upside +15%
🎯 on CI : 0% (1 call matured) · 📊 on Health : 46.5% · +1.6% (402 calls)
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
Wells Fargo ↗
Jul 31, 26
■ Equal-Weight neutral · not a buy · 🎯$307
Price at call : $282.06 — gap to target +9%
Today : $277.67 — gap to target +11%
🎯 on CI : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Guggenheim ↗
Jul 31, 26
▲ Buy · 🎯$361
Price at call : $282.06 — upside +28%
Today : $277.67 — upside +30%
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
■ Equal-Weight neutral · not a buy · 🎯$310
Price at call : $279.05 — gap to target +11%
Today : $277.67 — gap to target +12%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Outperform · 🎯$381
Price at call : $291.8 — upside +31%
Today : $277.67 — upside +37%
🎯 on CI : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
▲ Outperform · 🎯$340
Price at call : $295 — upside +15%
Today : $277.67 — upside +22%
🎯 on CI : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
■ Equal-Weight neutral · not a buy · 🎯$304
Price at call : $285.75 — gap to target +6%
Today : $277.67 — gap to target +9%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
See the other 64 calls, newest to oldest
▲ Buy · 🎯$400
Price at call : $280.83 — upside +42%
Today : $277.67 — upside +44%
🎯 on CI : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
Morgan Stanley ↗
May 20, 26
▲ Overweight · 🎯$361
Price at call : $282.02 — upside +28%
Today : $277.67 — upside +30%
🎯 on CI : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
Deutsche Bank ↗
May 20, 26
■ Hold neutral · not a buy · 🎯$302
Price at call : $283.1 — gap to target +7%
Today : $277.67 — gap to target +9%
🎯 on CI : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
▲ Outperform · 🎯$371
Price at call : $281.98 — upside +32%
Today : $277.67 — upside +34%
🎯 on CI : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : May 5, 27
matures : May 5, 27
Guggenheim ↗
May 4, 26
▲ Buy · 🎯$338
Price at call : $279.35 — upside +21%
Today : $277.67 — upside +22%
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
RBC Capital ↗
May 1, 26
▲ Outperform · 🎯$337
Price at call : $279.35 — upside +21%
Today : $277.67 — upside +21%
🎯 on CI : 0% (2 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Cantor Fitzgerald ↗
May 1, 26
▲ Overweight · 🎯$340
Price at call : $279.35 — upside +22%
Today : $277.67 — upside +22%
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Overweight · 🎯$310
Price at call : $279.35 — upside +11%
Today : $277.67 — upside +12%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Wells Fargo ↗
May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$305
Price at call : $279.35 — gap to target +9%
Today : $277.67 — gap to target +10%
🎯 on CI : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Buy · 🎯$330
Price at call : $276.69 — upside +19%
Today : $277.67 — upside +19%
🎯 on CI : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
▲ Outperform · 🎯$358
Price at call : $267.19 — upside +34%
Today : $277.67 — upside +29%
🎯 on CI : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Mar 12, 27
matures : Mar 12, 27
Piper Sandler ↗
Mar 3, 26
▲ Overweight · 🎯$370
Price at call : $284.74 — upside +30%
Today : $277.67 — upside +33%
🎯 on CI : 0% (1 call matured) · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
Truist Securities ↗
Feb 17, 26
▲ Buy · 🎯$350
Price at call : $290.12 — upside +21%
Today : $277.67 — upside +26%
🎯 on CI : 0% (1 call matured) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
▲ Buy · 🎯$338
Price at call : $287.81 — upside +17%
Today : $277.67 — upside +22%
🎯 on CI : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
RBC Capital ↗
Feb 6, 26
▲ Outperform · 🎯$333
Price at call : $294.4 — upside +13%
Today : $277.67 — upside +20%
🎯 on CI : 0% (2 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Overweight · 🎯$303
Price at call : $294.4 — upside +3%
Today : $277.67 — upside +9%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Guggenheim ↗
Feb 6, 26
▲ Buy · 🎯$334
Price at call : $294.4 — upside +13%
Today : $277.67 — upside +20%
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Guggenheim ↗
Feb 2, 26
▲ Buy · 🎯$318
Price at call : $275.39 — upside +15%
Today : $277.67 — upside +15%
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Truist Securities ↗
Jan 5, 26
▲ Buy · 🎯$320
Price at call : $284.76 — upside +12%
Today : $277.67 — upside +15%
🎯 on CI : 0% (1 call matured) · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Overweight · 🎯$305
Price at call : $283.97 — upside +7%
Today : $277.67 — upside +10%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
■ Market Perform neutral · not a buy · 🎯$294
Price at call : $270.61 — gap to target +9%
Today : $277.67 — gap to target +6%
🎯 on CI : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Wells Fargo ↗
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$300
Price at call : $256.38 — gap to target +17%
Today : $277.67 — gap to target +8%
🎯 on CI : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
▲ Buy · 🎯$333
Price at call : $259.58 — upside +28%
Today : $277.67 — upside +20%
🎯 on CI : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
Goldman Sachs ↗
Nov 4, 25
▲ Buy · 🎯$330
Price at call : $259.58 — upside +27%
Today : $277.67 — upside +19%
🎯 on CI : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$375
Price at call : $259.58 — upside +44%
Today : $277.67 — upside +35%
🎯 on CI : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$300
Price at call : $258.62 — upside +16%
Today : $277.67 — upside +8%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Goldman Sachs ↗
Oct 14, 25
▲ Buy · 🎯$370
Price at call : $302.13 — upside +22%
Today : $277.67 — upside +33%
🎯 on CI : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
▲ Overweight · 🎯$383
Price at call : $305.31 — upside +25%
Today : $277.67 — upside +38%
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Sep 4, 26
matures : Sep 4, 26
Cantor Fitzgerald ↗
Aug 26, 25
▲ Overweight · 🎯$365
Price at call : $300.32 — upside +22%
Today : $277.67 — upside +31%
Expected +22% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-6.5%
stock -6% · XLV +27%
matured Aug 26, 26
▲ Outperform · 🎯$374
Price at call : $296.86 — upside +26%
Today : $277.67 — upside +35%
Expected +26% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (1 call matured) · 📊 on Health : 51.7% · +6.5% (298 calls)
-7.2%
stock -7% · XLV +23%
matured Aug 14, 26
Wells Fargo ↗
Aug 14, 25
■ Equal-Weight neutral · not a buy · 🎯$340
Price at call : $296.86 — gap to target +15%
Today : $277.67 — gap to target +22%
🎯 on CI : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Aug 14, 26
matures : Aug 14, 26
Guggenheim ↗
Aug 4, 25
▲ Buy · 🎯$350
Price at call : $266.59 — upside +31%
Today : $277.67 — upside +26%
Expected +31% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
+2.8%
stock +3% · XLV +22%
matured Aug 4, 26
▲ Overweight · 🎯$354
Price at call : $262.23 — upside +35%
Today : $277.67 — upside +27%
Expected +35% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
+7.6%
stock +8% · XLV +24%
matured Aug 1, 26
RBC Capital ↗
Jun 26, 25
▲ Outperform · 🎯$371
Price at call : $326.31 — upside +14%
Today : $277.67 — upside +34%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (2 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-14.6%
stock -15% · XLV +20%
matured Jun 26, 26
RBC Capital ↗
Jun 3, 25
▲ Outperform · 🎯$371
Price at call : $310.12 — upside +20%
Today : $277.67 — upside +34%
Expected +20% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (2 calls matureds) · 📊 on Health : 42.8% · -2.4% (395 calls)
-9.5%
stock -9% · XLV +14%
matured Jun 3, 26
▲ Overweight · 🎯$385
Price at call : $311.67 — upside +24%
Today : $277.67 — upside +39%
Expected +24% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on CI : 50% (2 calls matureds) · 📊 on Health : 50.1% · +2.2% (629 calls)
-13.1%
stock -13% · XLV +11%
matured Jun 2, 26
Guggenheim ↗
May 23, 25
▲ Buy · 🎯$388
Price at call : $315.28 — upside +23%
Today : $277.67 — upside +40%
Expected +23% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-10.9%
stock -11% · XLV +12%
matured May 23, 26
Truist Securities ↗
May 12, 25
▲ Buy · 🎯$405
Price at call : $301.89 — upside +34%
Today : $277.67 — upside +46%
Expected +34% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (1 call matured) · 📊 on Health : 49.6% · +2.3% (260 calls)
-0.4%
stock -0% · XLV +11%
matured May 12, 26
Guggenheim ↗
May 6, 25
▲ Buy · 🎯$388
Price at call : $334.44 — upside +16%
Today : $277.67 — upside +40%
Expected +16% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-15.1%
stock -15% · XLV +7%
matured May 6, 26
Piper Sandler ↗
May 5, 25
▲ Overweight · 🎯$374
Price at call : $333.82 — upside +12%
Today : $277.67 — upside +35%
Expected +12% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (1 call matured) · 📊 on Health : 46.7% · -1.3% (321 calls)
-15.5%
stock -16% · XLV +8%
matured May 5, 26
Raymond James ↗
May 5, 25
▲ Strong Buy · 🎯$385
Price at call : $333.82 — upside +15%
Today : $277.67 — upside +39%
Expected +15% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (1 call matured) · 📊 on Health : 46.5% · +1.6% (402 calls)
-15.5%
stock -16% · XLV +8%
matured May 5, 26
Guggenheim ↗
May 5, 25
▲ Buy
Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on CI : 25% (4 calls matureds) · 📊 on Health : 54.6% · +4.4% (97 calls)
-15.5%
stock -16% · XLV +8%
matured May 5, 26
Cantor Fitzgerald ↗
Mar 20, 25
▲ Overweight · 🎯$365
Price at call : $316.65 — upside +15%
Today : $277.67 — upside +31%
Expected +15% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-17.4%
stock -17% · XLV -1%
matured Mar 20, 26
Stephens & Co. ↗
Jan 31, 25
▲ Overweight · 🎯$380
Price at call : $292.46 — upside +30%
Today : $277.67 — upside +37%
Expected +30% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-7.1%
stock -7% · XLV +6%
matured Jan 31, 26
Cantor Fitzgerald ↗
Jan 31, 25
▲ Overweight · 🎯$350
Price at call : $292.46 — upside +20%
Today : $277.67 — upside +26%
Expected +20% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-7.1%
stock -7% · XLV +6%
matured Jan 31, 26
Stephens & Co. ↗
Nov 1, 24
▲ Overweight · 🎯$410
Price at call : $312.32 — upside +31%
Today : $277.67 — upside +48%
Expected +31% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-17.2%
stock -17% · XLV -2%
matured Nov 1, 25
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$400
Price at call : $342.6 — upside +17%
Today : $277.67 — upside +44%
Expected +17% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-11.1%
stock -11% · XLV -11%
matured Aug 19, 25
Stephens & Co. ↗
Aug 2, 24
▲ Overweight · 🎯$410
Price at call : $325.71 — upside +26%
Today : $277.67 — upside +48%
Expected +26% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-18.1%
stock -18% · XLV -9%
matured Aug 2, 25
Cantor Fitzgerald ↗
Jul 10, 24
▲ Overweight · 🎯$400
Price at call : $333.56 — upside +20%
Today : $277.67 — upside +44%
Expected +20% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-9.1%
stock -9% · XLV -8%
matured Jul 10, 25
Cantor Fitzgerald ↗
Jun 12, 24
▲ Overweight · 🎯$400
Price at call : $334.15 — upside +20%
Today : $277.67 — upside +44%
Expected +20% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-5.0%
stock -5% · XLV -7%
matured Jun 12, 25
Cantor Fitzgerald ↗
May 3, 24
▲ Overweight · 🎯$400
Price at call : $342.41 — upside +17%
Today : $277.67 — upside +44%
Expected +17% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-2.8%
stock -3% · XLV -2%
matured May 3, 25
Cantor Fitzgerald ↗
Apr 10, 24
▲ Overweight · 🎯$384
Price at call : $353.08 — upside +9%
Today : $277.67 — upside +38%
Expected +9% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-6.5%
stock -6% · XLV -3%
matured Apr 10, 25
Cantor Fitzgerald ↗
Mar 8, 24
▲ Overweight · 🎯$384
Price at call : $342.27 — upside +12%
Today : $277.67 — upside +38%
Expected +12% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-4.5%
stock -5% · XLV +1%
matured Mar 8, 25
Cantor Fitzgerald ↗
Mar 4, 24
▲ Overweight · 🎯$372
Price at call : $332.73 — upside +12%
Today : $277.67 — upside +34%
Expected +12% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-6.9%
stock -7% · XLV +3%
matured Mar 4, 25
Cantor Fitzgerald ↗
Feb 5, 24
▲ Overweight · 🎯$372
Price at call : $321.27 — upside +16%
Today : $277.67 — upside +34%
Expected +16% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-9.3%
stock -9% · XLV +3%
matured Feb 4, 25
Stephens & Co. ↗
Jun 28, 23
▲ Overweight · 🎯$345
Price at call : $274.74 — upside +26%
Today : $277.67 — upside +24%
Expected +26% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+21.6%
stock +22% · XLV +12%
matured Jun 27, 24
Stephens & Co. ↗
Mar 21, 23
▲ Overweight · 🎯$370
Price at call : $276.62 — upside +34%
Today : $277.67 — upside +33%
Expected +34% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+27.9%
stock +28% · XLV +14%
matured Mar 20, 24
Stephens & Co. ↗
Feb 28, 23
▲ Overweight · 🎯$370
Price at call : $288.75 — upside +28%
Today : $277.67 — upside +33%
Expected +28% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+16.4%
stock +16% · XLV +14%
matured Feb 28, 24
Stephens & Co. ↗
Feb 6, 23
▲ Overweight · 🎯$370
Price at call : $288.44 — upside +28%
Today : $277.67 — upside +33%
Expected +28% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+13.6%
stock +14% · XLV +9%
matured Feb 6, 24
Stephens & Co. ↗
Apr 20, 22
▲ Overweight · 🎯$290
Price at call : $268.87 — upside +8%
Today : $277.67 — upside +4%
Expected +8% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
-4.9%
stock -5% · XLV -5%
matured Apr 20, 23
Stephens & Co. ↗
Aug 6, 21
▲ Overweight · 🎯$270
Price at call : $209.3 — upside +29%
Today : $277.67 — upside -3%
Expected +29% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+34.6%
stock +35% · XLV -1%
matured Aug 6, 22
Cantor Fitzgerald ↗
Feb 6, 20
▲ Overweight · 🎯$255
Price at call : $208.92 — upside +22%
Today : $277.67 — upside -8%
Expected +22% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on CI : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-1.4%
stock -1% · XLV +12%
matured Feb 5, 21
Stephens & Co. ↗
Jan 2, 20
▲ Overweight · 🎯$270
Price at call : $204.94 — upside +32%
Today : $277.67 — upside -3%
Expected +32% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+0.4%
stock +0% · XLV +11%
matured Jan 1, 21
Stephens & Co. ↗
Jan 14, 19
▲ Overweight · 🎯$251
Price at call : $192.05 — upside +31%
Today : $277.67 — upside -10%
Expected +31% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on CI : 64% (11 calls matureds) · 📊 on Health : 52.5% · +0.2% (99 calls)
+6.8%
stock +7% · XLV +19%
matured Jan 14, 20
Frequently asked questions
Should I buy Cigna stock?
This isn't buy advice. For Cigna, the analyst consensus is "Buy", with an average price target of $340 (+22% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Cigna). We show the numbers — you decide.
Is it too late to buy Cigna? How high can it go?
The most bullish analyst target on Cigna is $400 (+44% above today's price); the average is $340. That's the upside they see. Check how reliable those analysts have actually been on Cigna on our site before trusting it.
Is Cigna still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 29 analysts have a real record on Cigna, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Cigna? The case for and against
The arguments for and against, one by one, from the numbers: why invest in CI (and why hesitate).
What has Cigna's past performance been?
Historical returns and a "how much if I had invested" calculator: CI performance & returns.
Does Cigna pay a dividend?
Yield, consistency and growth history of the dividend: CI's dividend.
What is the best month to buy CI?
The 12 months ranked by the stock's past returns: best & worst month to buy CI.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX